Table 4.
Recommendations on the Management of Clozapine-Withdrawal-Induced Catatonia
| Recommendations | Type | Level of Evidence | Strength of Recommendation |
|---|---|---|---|
| Avoid abrupt discontinuation of clozapine to minimise risk of clozapine-withdrawal-induced catatonia | Consensus based | - | - |
| If feasible, re-initiate clozapine | Evidence-based | (III) evidence from non-experimental descriptive study | (C) Directly based on category III evidence |
| Consider benzodiazepine as an adjunctive treatment | Evidence-based | (III) evidence from non-experimental descriptive study | (C) Directly based on category III evidence |
| Where re-initiation of clozapine or use of benzodiazepines is not feasible, consider ECT | Evidence-based | (III) evidence from non-experimental descriptive study | (C) Directly based on category III evidence |